Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
Purity | ≥70% |
---|---|
Formula | C16H14N2O4 |
Formula Wt. | 298.29 |
Appearance | Red Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Endogenous peptide neurotransmitter, involved i...
NSAID; COX-2 inhibitor.
Impurity of omeprazole
α1-adrenergic antagonist.
Dihydrofolate reductase inhibitor.
G6PDH inhibitor.
Inhibitor of T-lymphokine-activated killer cell...
NMDA partial agonist, D-Ala-D-Ala ligase inhibi...
mAChR agonist, selective for M2.
ITC.
NSAID; NMDA inverse agonist, T-type Ca2+ and Cl...
CHK1 inhibitor.
DP1 antagonist.
Triterpene saponin found in species of Panax; 2...
Natriuretic, vasodilatory peptide fragment; B1/...
Hexokinase inhibitor, aerobic glycolysis inhibi...
Piroxicam prodrug, NSAID; COX-1/2 inhibitor.
Mycotoxin produced by Alternaria; photosynthesi...
Macrolide; peptidyl transferase inhibitor, prot...
Promotes degradation of cIAP1